Lornoxicam

Lornoxicam is a nonsteroidal anti-inflammatory drug (NSAID) used mainly for pain relief, reducing inflammation and swelling in conditions like rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis, as well as for acute pain. It works by blocking prostaglandins, chemical messengers causing pain and inflammation, and is also combined with paracetamol for broader pain management (headaches, dental pain) or thiocolchicoside for muscle spasms. It is grouped under the following drug class(es): Cyclooxygenase‑1 (COX‑1) Inhibitors, Cyclooxygenase‑2 (COX‑2) Inhibitors and Non-Steroidal Anti-Inflammatory Drugs (NSAID). Its therapeutic use is listed as analgesics, anti-inflammatories, antipyretics and osteoarthritis agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Chlortenoxicam, Xefocam and Xefo. Its PubChem CID is 54690031.

CAS No 70374-39-9
Molecular Formula C13H10ClN3O4S2
Molecular Weight 371.80 g/mol
Synonyms 6-chloro-4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-ylthieno[2,3-e]thiazine-3-carboxamide

Frequently Asked Questions